Abstract
Enhancing cocaine metabolism by administration of cocaine esterase (CocE) has been recognized as a promising treatment strategy for cocaine overdose and addiction, because CocE is the most efficient native enzyme for metabolizing the naturally occurring cocaine yet identified. A major obstacle to the clinical application of CocE is the thermoinstability of native CocE with a half-life of only a few minutes at physiological temperature (37°C). Here we report thermostable variants of CocE developed through rational design using a novel computational approach followed by in vitro and in vivo studies. This integrated computational-experimental effort has yielded a CocE variant with a ∼30-fold increase in plasma half-life both in vitro and in vivo. The novel design strategy can be used to develop thermostable mutants of any protein. Copyright © 2009 The American Society for Pharmacology and Experimental Therapeutics.
Cite
CITATION STYLE
Gao, D., Narasimhan, D. L., Macdonald, J., Brim, R., Ko, M. C., Landry, D. W., … Zhan, C. G. (2009). Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity. Molecular Pharmacology, 75(2), 318–323. https://doi.org/10.1124/mol.108.049486
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.